  | |  | Contents
| |
|
| |
|
| | Dear Sophie Allen,
|
| We’re getting started with the winter celebrations early! Read below to find out about our competition this month and how to enter for a chance to win one of four eBooks.
Another upcoming and exciting release is the new English translation of Hermann Rorschach’s Psychodiagnostics, in celebration of the Rorschach test’s 100th anniversary.
Thank you to all existing and new members of the Hogrefe community for your support over this past year and we wish you all a Happy Holiday!
Best,
|
| Your Hogrefe Publishing Team
| |
| |
|
|
| |
| | | | Mindfulness | | By Katie Witkiewitz / Corey R. Roos / Dana Dharmakaya Colgan / Sarah Bowen
We’re delighted to present our “Book of the Month” this December 2021.
This book provides practical, evidence-based guidance on the use of mindfulness in treatment.
To find out more about what being a book of the month entails (hint: It includes a discount code!) click on the link below.
|
| | Find out more |
|
|
| |
|
| |
| | |
Giveaways for the Winter Holidays! | | Here is your chance to win one of four eBooks over the holidays. Click below for details on how to enter our Winter Wordsearch Competition!
|
| | Click here |
| |
|
|
|
| |
| | | | Hermann Rorschach’s Psychodiagnostics: Newly Translated and Annotated 100th Anniversary Edition | | Edited by Philip J. Keddy / Rita Signer / Philip Erdberg / Arianna Schneider-Stocking
Completely new translation of Rorschach’s Psychodiagnostics
This new English translation and 100th anniversary annotated edition of Psychodiagnostics, the only book published by Hermann Rorschach, showcases Rorschach’s empiricism and the wide-ranging flexibility of his thinking – and thus helps us to understand why his iconic inkblot test has survived for a century and is still being used around the world, with the support of a strong evidence base.
|
| | Read more |
|
|
| |
|
| |
|
| | | | Clinical Handbook of Psychotropic Drugs for Children and Adolescents Online | | ADHD update coming December 6, 2021
We’re pleased to announce that an update of the ADHD section of the CHPD for Children and Adolescents Online will be released on December 6, 2021.
The update will include the selective norepinephrine reuptake inhibitor viloxazine (trade name Qelbree), a nonstimulant medication approved by the FDA in 2021 for the treatment of ADHD in children and adolescents aged 6–17, the first new ADHD treatment to be approved in over a decade. We’re also adding a Patient and Caregiver Information Sheet on viloxazine.
Further revisions include additional formulations of other treatments: Adhansia XR (methylphenidate extended-release capsules), Evekeo ODT (amphetamine orally disintegrating tablets), Jornay PM (methylphenidate delayed-release/extended-release capsules), and Vyvanse (lisdexamfetamine) chewable tablets.
|
| | To the online platform |
|
|
| |
|
| |
|
| | | | Are we giving boys a voice? | | “As a society, we still have a way to go towards encouraging men and boys to be both self-compassionate and compassionate towards others.”
– By Dr. Christine Wekerle
|
| | To the article |
| |
|
|
|
| |
| | | | European Journal of Health Psychology | | Behavior during the COVID-19 pandemic.
One of the themes in this latest issue focuses on attitudes about and during the COVID-19 pandemic: Social comparisons for following the health recommendations, wellbeing and resilience, and looking at social distancing among adolescents.
|
| | Read more |
|
|
| |
|
| |
| | | | Journal of Individual Differences | | Are you a risk-taker?
An original article in this latest issue examines the personality profile of risk takers; other articles focus on messaging services and data protection, romantic attachment, and socially desirable responding in experience sampling.
|
| | Read more |
|
|
| |
|
| |
| |
| |
|
|
